Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 6 (9) , 477-482
- https://doi.org/10.1046/j.1469-0691.2000.00128.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Assessing the evidence that antibiotic growth promoters influence human infectionsJournal of Hospital Infection, 1999
- Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, GermanyJournal of Hospital Infection, 1999
- Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faeciumClinical Microbiology & Infection, 1999
- Glycopeptide Resistance inEnterococcus faeciumfrom Broilers and Pigs Following Discontinued Use of AvoparcinMicrobial Drug Resistance, 1999
- The Use of Avoparcin as a Growth Promoter and the Occurrence of Vancomycin-ResistantEnterococcusSpecies in Norwegian Poultry and Swine ProductionMicrobial Drug Resistance, 1999
- Vancomycin-resistant Gram-positive cocci: risk factors for faecal carriageJournal of Hospital Infection, 1997
- Characterization of vancomycin resistance in Enterococcus duransJournal of Antimicrobial Chemotherapy, 1995
- The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents—a preliminary reportJournal of Hospital Infection, 1995
- Serious Infections Caused by Multiply-Resistant Enterococcus faeciumMicrobial Drug Resistance, 1995
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988